Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can facebook ads help detect lung cancer earlier?

NCT ID NCT05824273

Knowledge-focused Sponsor: Hackensack Meridian Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether Facebook ads and a personalized online tool called LungTalk could increase awareness and knowledge about lung cancer screening among people at high risk. Over 500 participants with a history of heavy smoking were recruited through Facebook. The goal was to see if these methods could encourage more people to talk to their doctor and get screened.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
LungTalk (computer-tailored health communication tool) and Facebook-targeted advertisements
What this could lead to
If successful, this approach could help more high-risk people learn about and get screened for lung cancer, potentially catching it earlier.
What could go wrong
This is a completed study focused on awareness and knowledge, not on actual cancer outcomes. The results may not lead to widespread changes in screening behavior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

512 people

The number who actually took part.

Started

Aug 2023

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥20-pack-year smoking history; * Individuals who currently smoke or quit smoking within the past 15 years Exclusion Criteria: * Previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed * Has ever been diagnosed with lung cancer * Individuals with impaired decision-making (because our primary outcome is decision-making, we will not include individuals with impaired decision-making)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer

Contacts and locations

Locations

  • Hackensack Meridian Health - Center for Discovery and Innovation

    Nutley, New Jersey, 07110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.